期刊文献+

射频和微波消融治疗肝癌并发症分析 被引量:24

Complications of thermal ablation of liver cancer: comparison of radiofrequency and microwave techniques
原文传递
导出
摘要 【摘要】目的分析热消融治疗肝癌并发症的原因及防治措施,并比较射频消融(RFA)和微波消融(MwA)两种消融技术的安全性。方法对879例肝癌患者实施热消融治疗,RFA组323例,MWA组556例,比较两种消融技术治疗肝癌的并发症。结果879例患者1_652个肿瘤共接受1030次热消融治疗。323例562个肿瘤接受376次RFA;556例1090个肿瘤接受654次MwA。RFA组和MwA组死亡、严重并发症、轻微并发症发生率分别为0.31%(1/323)、3.5%(13/376)、5.90o(22/376)和0.36%(2/556)、3.1%(20/654)、5.7%(37/654)。两组比较差异无统计学意义(P〉0.05)。结论热消融治疗肝癌是安全的,死亡和严重并发症发生率较低,而且MWA与RFA具有相同的安全性。 Objective To investigate the common complications of thermal ablations of liver cancer using both radiofrequency ablation (RFA) and microwave ablation (MWA) techniques, and compare the safety between these two procedures. Methods A total of 879 patients with hepatic tumors underwent thermal ablation. There were 323 cases having the RFA procedures and 556 cases having MWA procedures. The complications of thermal ablations of liver cancer were compared using both RFA and MWA techniques. Results A total of 1030 thermal ablation sessions was performed in 879 patients with a total of 1652 tumors. There were 323 patients with 562 tumors received a total of 376 RFA. The other 556 patients with 1090 tumors received a total of 654 MWA. The mortality rates were 0.31% (1/323) and 0.36% (2/ 556) in RFA and MWA group. In RFA and MWA group,the major complication rates were 3.5%(13/376) and 3. 1% (20/654) ,meanwhile the minor complication rates were 5.9%(22/376) and 5.7% (37/654). There was no statistical significant difference for the mortality rates, the major complications, the minor complications between the RFA and MWA groups ( P 〉0. 05). Conclusions Thermal ablation therapy in the treatment of liver cancers is relatively safe with low mortality and low incidence of serious complications. The types and incidences of complications caused by RFA and MWA are similar and comparable for safety consideration in clinical settings.
出处 《中华超声影像学杂志》 CSCD 北大核心 2013年第6期500-504,共5页 Chinese Journal of Ultrasonography
关键词 超声检查 肝肿瘤 导管消融术 微波 治疗应用 并发症 Ultrasonography Liver neoplasms Catheter ablation Microwave/therapeutic use Complications
  • 相关文献

参考文献2

二级参考文献30

  • 1Zhou L, Rui JA, Wang SB, Chen SG, Qu Q, Chi TY, Wei X, Han K, Zhang N, Zhao HT. Outcomes and prognostic factors of cirrhotic patients with hepatocellular carcinoma after radical major hepatectomy. World J Surg 2007; 31: 1782-1787.
  • 2Shimozawa N, Hanazaki K. Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 2004; 198:356-365.
  • 3Vogl TJ, Zangos S, Balzer JO, Nabil M, Rao P, Eichler K, Bechstein WO, Zeuzem S, Abdelkader A. [Transarterial chemoembolization (TACE) in hepatocellular carcinoma: technique, indication and results] Rofo 2007; 179:1113-1126.
  • 4Mazzanti R, Arena U, Pantaleo P, Antonuzzo L, Cipriani G, Neri B, Giordano C, Lanini F, Marchetti S, Gentilini P. Survival and prognostic factors in patients with hepatocellular carcinoma treated by percutaneous ethanol injection: a 10-year experience. Can J Gastroenterol 2004; 18: 611-618.
  • 5Crocetti L, Lencioni R. Thermal ablation of hepatocellular carcinoma. Cancer Imaging 2008; 8:19-26.
  • 6Yan K, Chen MH, Yang W, Wang YB, Gao W, Hao CY, Xing BC, Huang XF. Radiofrequency ablation of hepatocellular carcinoma: long-term outcome and prognostic factors. Eur J Radiol 2008; 67:336-347.
  • 7Lencioni R, Crocetti L. Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol 2007; 10:38-46.
  • 8Vails C, Ruiz S, Barrau V, Burdio F, Llado L, Figueras J, Vilgrain V. [Radiofrequency ablation of hepatic tumors] Radiologia 2006; 48:53-69.
  • 9Perkins JD. Seeding risk following percutaneous approach to hepatocellular carcinoma. Liver Transpl 2007; 13:1603.
  • 10Chen TM, Huang PT, Lin LF, Tung JN. Major complications of ultrasound-guided percutaneous radiofrequency ablations for liver malignancies: single center experience. J Gastroenterol Hepatol 2008; 23:e445-e450.

共引文献133

同被引文献162

引证文献24

二级引证文献220

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部